IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

About IAVI’s Marburg virus vaccine program

IAVI is developing a vaccine candidate for protection against Marburg virus (MARV), a deadly pathogen and potential bioweapon that repeatedly causes severe outbreaks.

Read more

About IAVI’s Sudan virus vaccine program

IAVI is developing a vaccine candidate for protection against Sudan virus (SUDV) and has contributed to outbreak responses in sub-Saharan Africa. 

Read more

Features

Fast facts about IAVI’s contributions to fighting Lassa fever in West Africa

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Lassa virus, since 2018.

Read more

Features

Fast facts about the preclinical data supporting IAVI’s Marburg virus vaccine candidate

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Marburg virus, since 2018.

Read more

Features

Frequently asked questions: Lassa fever

September 11, 2025

Learn more about Lassa virus, a zoonotic virus that causes severe hemorrhagic fever in humans.

Read more

Features

Frequently asked questions: Marburg virus disease

September 11, 2025

Learn more about Marburg virus, a filovirus that causes a severe hemorrhagic illness in humans.

Read more

Features

Frequently asked questions: Sudan virus disease

September 11, 2025

Learn more about Sudan virus, a filovirus that causes severe hemorrhagic illness in humans.

Read more

Press Releases

West African leaders commit to advance Lassa fever vaccine for the region

September 9, 2025

In an historic moment for regional solidarity and leadership, West African Ministers of Health pledge their joint commitment to advance the development of, and readiness for, much-needed vaccines against Lassa fever in recognition of the significant threat to regional health security posed by the disease.

Read more